Clinical Trials Logo

Chronic Lymphoblastic Leukemia clinical trials

View clinical trials related to Chronic Lymphoblastic Leukemia.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04796688 Recruiting - Clinical trials for Acute Lymphoblastic Leukemia

Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies

Start date: March 10, 2021
Phase: Phase 1
Study type: Interventional

This is a single-center, open-label, single-arm study to evaluate the primary safety and efficacy of universal chimeric antigen receptor-modified AT19 cells in patients with relapsed or refractory hematological malignancies.

NCT ID: NCT04028440 Recruiting - Clinical trials for Non-Hodgkin's Lymphoma

γδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)

Start date: October 2019
Phase: Early Phase 1
Study type: Interventional

This study aims to evaluate the safety and efficacy of autologous γδT cells in patients with relapsed or refractory B cell non-Hodgkin's lymphoma (B-NHL), chronic lymphoblastic leukemia (CLL) and peripheral T cell lymphoma (PTCL) expect for γδT lymphoma.